FDA Approves First Treatment for Ebola Virus
The U.S. Food and Drug Administration has approved Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn), a mixture of three monoclonal antibodies, as the first FDA-approved treatment for Zaire ebolavirus (Ebola virus) infection in …
Read More